Business Context and Reporting Period
Company: PHOTRONICS, INC.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: July 31, 1996
Business Overview: Photronics manufactures photomasks for the semiconductor industry. The reporting period reflects significant global expansion, including the acquisition of operations in the United Kingdom (Plessey) and Switzerland (Litomask), and the commencement of capacity expansion programs in Allen, Texas, and Singapore.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended July 31, 1996 |
Nine Months Ended July 31, 1996 |
Nine Months Ended July 31, 1995 |
|---|---|---|---|
| Net Sales | $42,677 | $117,859 | $89,067 |
| Cost of Sales | $26,249 | $72,312 | $54,854 |
| Gross Margin % | 38.5% | 38.6% | 38.4% |
| Operating Income | $8,623 | $23,762 | $15,957 |
| Net Income | $5,513 | $15,431 | $13,547 |
| Diluted EPS | $0.46 | $1.28 | $1.24 |
| Cash & Equivalents (Balance Sheet) | $26,967 (as of July 31, 1996) | ||
| Net Cash from Operations (9mo) | $24,528 | ||
| Total Debt (Current + Long-term) | $1,819 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 29.9% for the quarter and 32.3% for the nine-month period compared to the prior year. Growth was driven by increased manufacturing capacity, higher average selling prices for complex photomasks, and the inclusion of new European facilities.
- Profitability: Operating income rose 66.7% for the quarter and 48.9% for the nine-month period. Net income increased 23.0% (quarter) and 33.4% (nine-month) on an adjusted basis, excluding non-recurring items from the prior year.
- Expense Trends: Cost of sales increased proportionally with revenue. Selling, general, and administrative (SG&A) expenses rose due to global expansion but decreased as a percentage of sales (13.1% vs. 13.7% for the quarter). Research and development (R&D) expenses decreased 30.2% for the quarter primarily due to a one-time $1.5 million charge in the prior year related to the Microphase acquisition; excluding this, R&D increased 31.0%.
- Investment Income: Interest and other income dropped significantly ($5.2M to $0.3M for the quarter) due to the absence of a $4.7M gain from the sale of an equity investment in the prior year.
Guidance, Outlook, and Risks
- Capacity Expansion: The company is executing a major capacity expansion program. New facilities in Allen, Texas, and Singapore are expected to commence operations in the last quarter of fiscal 1996. A new facility in Manchester, UK, is planned for relocation within one year.
- Capital Commitments: As of July 31, 1996, the company had outstanding capital expenditure commitments of approximately $51 million for new facilities and advanced equipment.
- Liquidity: Cash and cash equivalents decreased by $24.9 million during the nine-month period, primarily due to $40.8 million in capital expenditures and $12.5 million in acquisitions. Management believes current resources and access to financing are sufficient to meet future requirements.
- Risks: The company anticipates increased fixed operating costs associated with capacity expansion. Margins at recently acquired operations and the Beta Squared subsidiary are currently lower than the company average.
Investor Verification Checklist
- Capital Expenditure Execution: Verify the timeline and cost adherence for the $51 million in committed capital expenditures, specifically the Texas and Singapore facilities.
- Acquisition Integration: Monitor the integration and margin performance of the Plessey (UK) and Litomask (Switzerland) acquisitions, which currently report lower margins.
- Cash Flow Sustainability: Assess whether operating cash flow ($24.5M for 9 months) will remain sufficient to fund the aggressive expansion without requiring significant new equity or debt issuance.
- Product Mix Shift: Confirm the continued shift toward higher-margin, complex photomasks (phase shift, optical proximity correction) to offset rising fixed costs.